Home » Topics » BioWorld Science

BioWorld Science
RSS

Potential new anticoagulants in development at Sanofi-Synthelabo

Nov. 16, 2001

Start of phase II trial of NCX-4016 following presentation of promising preclinical data

Nov. 16, 2001

NIH awards two grants to Progenics for development of innovative HIV therapies

Nov. 16, 2001

GSK and Bayer sign worldwide copromotion agreement for vardenafil in erectile dysfunction

Nov. 16, 2001

First in vivo data supporting selective inhibition of ERK1/2 in osteoarthritis therapy

Nov. 16, 2001

Kineret cleared for U.S. marketing, extensively covered at ACR/ARHP meeting

Nov. 16, 2001

Japanese approval sought by Mochida for new DIC treatment

Nov. 16, 2001

Antiasthmatic agent developed in Japan advances to clinical testing overseas

Nov. 16, 2001

Nitrate compound GT-715 appears to represent new approach to neurodegenerative disease therapy

Nov. 16, 2001

FDA approves Coreg for the treatment of severe heart failure

Nov. 16, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...